Ittai Ben Porath, The Hebrew University of Jerusalem
Arkaitz Carracedo. CIC bioGUNE
Webster Cavenee, Central Nervous System Cancers Ludwig Institute for Cancer Research
Rony Dahan, Weizmann Institute of Science
John Dick, Princess Margaret Cancer Centre, University Health Network
Ayelet Erez, Weizmann Institute of Science
Eyal Gottlieb,Technion-Israel Institute of Technology
Yona Keisari, Tel Aviv University
Mary Claire King, University of Washington
Alan Korman, Vir Biotechnology
Valery Krizhanovsky, Weizmann Institute of Science
Sima Lev, Weizmann Institute of Science
Scott Lowe, Geoffrey Beene Cancer Research Center Sloan Kettering Institute
David Malkin, University of Toronto
Moshe Oren, Weizmann Institute of Science
Gidi Rechavi, The Chaim Sheba Medical Center
Varda Rotter, Weizmann Institute of Science
Yardena Samuels, Weizmann Institute of Science
Avigdor Scherz, Weizmann Institute of Science
Ruth Scherz-Shouval, Weizmann Institute of Science
Avi Schroeder, Technion – Israel Institute of Technology
Yuval Shaked, Technion – Israel Institute of Technology
Ravid Straussman, Weizmann Institute of Science
Craig Thompson, Cancer Biology & Genetics Program Memorial Sloan Kettering
Cancer Center
Andreas Trumpp, Deutsches Krebsforschungszentrum Im Neuenheimer
David Tuveson, Cancer Center Cold Spring Harbor Laboratory
Val Weaver, University of California
Jedd Wolchok, Parker Institute for Cancer Immunotherapy